Back to search
FDAFDA · Food and drugs·Recall number D-0454-2025

Indomethacin Extended-Release Capsules, USP, 75 mg, 30 capsules (3 x 10 blister cards) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 68084-411-21 (carton), NDC 68084-411-11 (blister card).

Published June 11, 2025 · Recall initiated: May 15, 2025

Summary

FDA records drug Class II recall D-0454-2025, published June 11, 2025 and initiated May 15, 2025. Recalling firm: Amerisource Health Services LLC; Status: Ongoing; Reported quantity: 21 cartons; Lot: Lot #: 1021950, Exp. 11/30/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP deviations

What to do

Voluntary: Firm initiated · Letter

Get an email if INDOMETHACIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
INDOMETHACIN
Manufacturer
Amerisource Health Services LLC
Distributor
Nationwide in the USA
Lot
Lot #: 1021950, Exp. 11/30/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Indomethacin Extended-Release Capsules, USP, 75 mg, 30 capsules (3 x 10 blister cards) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 68084-411-21 (carton), NDC 68084-411-11 (blister card). recalled?

Yes. FDA published recall D-0454-2025 on June 11, 2025. Reported hazard: cGMP deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: INDOMETHACIN.